Viewing Study NCT00005857


Ignite Creation Date: 2025-12-24 @ 6:52 PM
Ignite Modification Date: 2025-12-31 @ 4:20 AM
Study NCT ID: NCT00005857
Status: COMPLETED
Last Update Posted: 2011-10-20
First Post: 2000-06-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy
Sponsor: City of Hope Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module